July 14 (Reuters) - Episurf Medical AB EPISb.ST :
* EPISURF MEDICAL: STRATEGY UPDATE TO TAKE THE NEXT
COMMERCIAL
STEPS AND IMPROVE FINANCIAL RESULTS
* STRATEGIC FOCUS THAT BRINGS INCREASED FOCUS ON US MARKET,
TRANSITION TO A DISTRIBUTOR MODEL FOR OTHER KEY MARKETS
* MEASURES ARE EXPECTED TO REDUCE OPERATIONAL COSTS BY
APPROXIMATELY SEK 25 MILLION ON AN ANNUAL BASIS.
* ONE-TIME EXPENSE OF SEK 4M RELATED TO STRATEGIC FOCUS WILL
BE
CHARGED IN COMPANY'S Q2 2023 REPORT.
* ANNOUNCES THAT PLAN IS TO MAKE SEVERAL POSITIONS
REDUNDANT.
* EXPECTS THAT CURRENT FUNDING WILL BE SUFFICIENT TO LAUNCH
BOTH
EPISEALER® PATELLOFEMORAL SYSTEM AND EPISEALER® MTP SYSTEM
* BELIEVES PROFITABILITY CAN BE ACHIEVED MORE QUICKLY, AND
CAPITAL
REQUIREMENTS ARE SIGNIFICANTLY LESS, THAN WHAT COST INDICATED
Source text for Eikon: ID:nWkr9Xz0g8
Further company coverage: EPISb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))